{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:03:56Z","timestamp":1758845036538,"version":"3.44.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100014421","name":"EA Pharma Co., Ltd.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014421","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014421","name":"EA Pharma Co., Ltd.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014421","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.ygyno.2018.04.009","type":"journal-article","created":{"date-parts":[[2018,4,13]],"date-time":"2018-04-13T09:05:46Z","timestamp":1523610346000},"page":"513-519","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Postoperative chemotherapy for node-positive cervical cancer: Results of a multicenter phase II trial (JGOG1067)"],"prefix":"10.1016","volume":"149","author":[{"given":"Maki","family":"Matoda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuhiro","family":"Takeshima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirofumi","family":"Michimae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Iwata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harushige","family":"Yokota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaka","family":"Torii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yorito","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiro","family":"Takehara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2526-630X","authenticated-orcid":false,"given":"Shin","family":"Nishio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6465-7883","authenticated-orcid":false,"given":"Hirokuni","family":"Takano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3151-8315","authenticated-orcid":false,"given":"Mika","family":"Mizuno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiyuki","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Takei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuya","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7496-3518","authenticated-orcid":false,"given":"Mikio","family":"Mikami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Enomoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toru","family":"Sugiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2018.04.009_bb0005","doi-asserted-by":"crossref","first-page":"5802","DOI":"10.1200\/JCO.2008.16.4368","article-title":"Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: a systematic review and meta-analysis of individual patient data from 18 randomized trials","volume":"26","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2018.04.009_bb0010","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1111\/j.1525-1438.2008.01195.x","article-title":"Treatment options in bulky stage IB cervical carcinoma","volume":"18","author":"Petsuksiri","year":"2008","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2018.04.009_bb0015","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.ygyno.2006.04.019","article-title":"Treatment results of adjuvant chemotherapy after radical hysterectomy for intermediate- and high-risk stage IB-IIA cervical cancer","volume":"103","author":"Takeshima","year":"2006","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2018.04.009_bb0020","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/j.1447-0756.2008.00739.x","article-title":"Treatment of cervical cancer with adjuvant chemotherapy versus adjuvant radiotherapy after radical hysterectomy and systematic lymphadenectomy","volume":"34","author":"Hosaka","year":"2008","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"10.1016\/j.ygyno.2018.04.009_bb0025","first-page":"977","article-title":"Adjuvant chemotherapy after radical hysterectomy for cervical carcinoma: a comparison with effects of adjuvant radiotherapy","volume":"91","author":"Iwasaka","year":"1998","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2018.04.009_bb0030","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1002\/jso.22136","article-title":"Clinical efficacy of paclitaxel\/cisplatin as an adjuvant chemotherapy for patients with cervical cancer who underwent radical hysterectomy and systemic lymphadenectomy","volume":"105","author":"Hosaka","year":"2012","journal-title":"J. Surg. Oncol."},{"key":"10.1016\/j.ygyno.2018.04.009_bb0035","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.ygyno.2012.07.104","article-title":"Neoadjuvant chemotherapy plus radical surgery followed by chemotherapy in locally advanced cervical cancer","volume":"127","author":"Angioli","year":"2012","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2018.04.009_bb0040","article-title":"Adjuvant chemotherapy, a valuable alternative option in selected patients with cervical cancer","volume":"8","author":"Li","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ygyno.2018.04.009_bb0045","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1006\/gyno.1999.5343","article-title":"Chemotherapy versus radiotherapy versus observation for high-risk cervical carcinoma after radical hysterectomy: a randomized, postoperative, multicenter trial","volume":"73","author":"Lahousen","year":"1999","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2018.04.009_bb0050","first-page":"265","article-title":"Five classes of extended hysterectomy for women with cervical cancer","volume":"44","author":"Piver","year":"1974","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2018.04.009_bb0055","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.3892\/or_00000316","article-title":"Phase I study of combination chemotherapy with irinotecan hydrochloride and nedaplatin for cervical squamous cell carcinoma: Japanese Gynecologic Oncology Group study","volume":"21","author":"Yamamoto","year":"2009","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.ygyno.2018.04.009_bb0060","first-page":"202","article-title":"In vitro synergistic interactions between the cisplatin analogue nedaplatin and the DNA topoisomerase I inhibitor irinotecan and the mechanism of this interaction","volume":"7","author":"Kanazawa","year":"2001","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ygyno.2018.04.009_bb0065","first-page":"375","article-title":"Comparison of cytotoxicity and cell kinetic perturbations of five platinum compounds in gynecologic cancer cell lines","volume":"3","author":"Nguyen","year":"1993","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.ygyno.2018.04.009_bb0070","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000012076","article-title":"Phase II study of irinotecan and cisplatin as first-line chemotherapy in advanced or recurrent cervical cancer","volume":"58","author":"Sugiyama","year":"2000","journal-title":"Oncology"},{"key":"10.1016\/j.ygyno.2018.04.009_bb0075","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/sj.bjc.6690656","article-title":"Combination therapy with irinotecan and cisplatin as neoadjuvant chemotherapy in locally advanced cervical cancer","volume":"81","author":"Sugiyama","year":"1999","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ygyno.2018.04.009_bb0080","first-page":"1569","article-title":"A phase 2 multicenter study of irinotecan and cisplatinum as neoadjuvant treatment in patients with locally advanced cervical cancer","volume":"20","author":"Raspagliesi","year":"2010","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2018.04.009_bb0085","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ygyno.2010.07.031","article-title":"Neoadjuvant chemotherapy followed by radical hysterectomy plus postoperative chemotherapy but no radiotherapy for Stage IB2-IIB cervical cancer - irinotecan and platinum chemotherapy","volume":"119","author":"Matsumura","year":"2010","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2018.04.009_bb0090","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1159\/000072333","article-title":"Phase I study of combination chemotherapy using irinotecan hydrochloride and nedaplatin for advanced or recurrent cervical cancer","volume":"65","author":"Machida","year":"2003","journal-title":"Oncology"},{"key":"10.1016\/j.ygyno.2018.04.009_bb0095","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1038\/sj.bjc.6602076","article-title":"Phase I-II study of irinotecan plus nedaplatin with recombinant human granulocyte colony-stimulating factor support in patients with advanced or recurrent cervical cancer","volume":"91","author":"Tsuda","year":"2004","journal-title":"Br. J. Cancer"},{"issue":"Suppl. 14","key":"10.1016\/j.ygyno.2018.04.009_bb0100","doi-asserted-by":"crossref","first-page":"5088","DOI":"10.1200\/jco.2004.22.90140.5088","article-title":"Phase II study of combination chemotherapy using irinotecan and nedaplatin for patients with primary advanced or recurrent cervical cancer","volume":"22","author":"Ohwada","year":"2004","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2018.04.009_bb0105","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/0090-8258(92)90251-D","article-title":"A randomized trial of adjuvant chemotherapy after radical hysterectomy in stage Ib-IIa cervical cancer patients with pelvic lymph node metastasis","volume":"46","author":"Tattersall","year":"1992","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2018.04.009_bb0110","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1200\/JCO.2000.18.8.1606","article-title":"Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix","volume":"18","author":"Peters","year":"2000","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2018.04.009_bb0115","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.ygyno.2004.11.007","article-title":"Rethinking the use of radiation and chemotherapy after radical hysterectomy: a clinical-pathologic analysis of a Gynecologic Oncology Group\/Southwest Oncology Group\/Radiation Therapy Oncology Group trial","volume":"96","author":"Monk","year":"2005","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2018.04.009_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/S1470-2045(16)30032-8","article-title":"Oncological outcomes after fertility-sparing surgery for cervical cancer: a systemic review","volume":"17","author":"Bentivegna","year":"2016","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ygyno.2018.04.009_bb0125","article-title":"The prognostic impact of the number of metastatic lymph nodes and a new prognostic scoring system for recurrence in early-stage cervical cancer with high risk factors: a multicenter cohort study (KROG 15-04)","author":"Kwon","year":"2017","journal-title":"Cancer Res. Treat."},{"key":"10.1016\/j.ygyno.2018.04.009_bb0130","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.ijrobp.2015.09.001","article-title":"Postoperative chemoradiation therapy in high-risk cervical cancer: re-evaluating the findings of gynecologic oncology group study 109 in large, population-based cohort","volume":"93","author":"Trifiletti","year":"2015","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.ygyno.2018.04.009_bb0135","first-page":"545","article-title":"Adjuvant chemotherapy versus radiation therapy after radical surgery in high-risk positive node StageIB\/IIA cervical cancer","volume":"31","author":"Mossa","year":"2010","journal-title":"Eur. J. Gynaecol. Oncol."},{"key":"10.1016\/j.ygyno.2018.04.009_bb0140","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/IGC.0b013e31819c9fa0","article-title":"Postoperative adjuvant chemotherapy for node-positive cervical cancer","volume":"19","author":"Takeshima","year":"2009","journal-title":"Int. J. Gyn. Oncol."},{"key":"10.1016\/j.ygyno.2018.04.009_bb0145","doi-asserted-by":"crossref","first-page":"487","DOI":"10.3892\/or.2012.1814","article-title":"Phase II study of neoadjuvant chemotherapy with irinotecan hydrochloride and nedaplatin followed by radical hysterectomy for bulky stage Ib2 to IIb, cervical squamous cell carcinoma: Japanese Gynecologic Oncology Group study (JGOG 1065)","volume":"28","author":"Yamaguchi","year":"2012","journal-title":"Oncol. Rep."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825818302865?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825818302865?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T03:38:27Z","timestamp":1758771507000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825818302865"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S0090825818302865"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2018.04.009","relation":{},"ISSN":["0090-8258"],"issn-type":[{"type":"print","value":"0090-8258"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Postoperative chemotherapy for node-positive cervical cancer: Results of a multicenter phase II trial (JGOG1067)","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2018.04.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}